Nanosphere Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 142

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $92.4M

  • Investors
  • 1

Nanosphere General Information

Description

molecular diagnostic tests. The company engages in research and development of diagnostic test platform that helps in disease detection, optimal patient treatment and improved healthcare economics.

Contact Information

Website
www.nanosphere.us
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 4088 Commercial Avenue
  • Northbrook, IL 60062
  • United States
+1 (847)
Primary Industry
Diagnostic Equipment
Acquirer
Luminex
Vertical(s)
AdTech, TMT
Corporate Office
  • 4088 Commercial Avenue
  • Northbrook, IL 60062
  • United States
+1 (847)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanosphere Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Merger/Acquisition 30-Jun-2016 $92.4M Completed Generating Revenue
12. Secondary Transaction - Open Market 17-May-2016 Completed Generating Revenue
11. Secondary Transaction - Open Market 31-Dec-2015 Completed Generating Revenue
10. PIPE 11-May-2015 Completed Generating Revenue
9. Debt - General 07-May-2015 Completed Generating Revenue
8. PIPE 19-Jul-2012 Completed Generating Revenue
7. IPO 01-Nov-2007 Completed Generating Revenue
6. Later Stage VC (Series D) 26-Apr-2006 Completed Generating Revenue
5. Later Stage VC (Series C2) 14-Oct-2004 $17M $44.4M Completed Startup
4. Later Stage VC (Series C) 26-Nov-2002 $15M $27.4M Completed Startup
To view Nanosphere’s complete valuation and funding history, request access »

Nanosphere Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C2
Series C 10,066,673 $0.010000 8% $0.6 $0.6 1x $0.6 2.24%
Series B 17,007 $0.010000 8% $2.21 $2.21
To view Nanosphere’s complete cap table history, request access »

Nanosphere Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
molecular diagnostic tests. The company engages in research and development of diagnostic test platform that helps in di
Diagnostic Equipment
Northbrook, IL
142 As of 2016

Mechelen, Belgium
 

Nehren, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanosphere Competitors (31)

One of Nanosphere’s 31 competitors is Biocartis, a Venture Capital-Backed company based in Mechelen, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocartis Venture Capital-Backed Mechelen, Belgium
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
BioGenex Laboratories Corporation Fremont, CA
Chembio Diagnostic Systems Corporate Backed or Acquired Medford, NY
Response Genetics Corporate Backed or Acquired Los Angeles, CA
You’re viewing 5 of 31 competitors. Get the full list »

Nanosphere Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanosphere Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Allen & Company. Investment Bank Minority
Bain Capital Ventures Venture Capital Minority
Lurie Investment Fund Corporate Venture Capital Minority
N*GEN Partners Venture Capital Minority
Oxford Finance Lender/Debt Provider
You’re viewing 5 of 9 investors. Get the full list »

Nanosphere Investments (1)

Nanosphere’s most recent deal was a Corporate Asset Purchase with Eppendorf (Certain Patents and Patent Rights) for . The deal was made on 18-Aug-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Eppendorf (Certain Patents and Patent Rights) 18-Aug-2010 Corporate Asset Purchase Buildings and Property
To view Nanosphere’s complete investments history, request access »

Ready to get started?

Request a free trial

Nanosphere FAQs

  • When was Nanosphere founded?

    Nanosphere was founded in 1999.

  • Where is Nanosphere headquartered?

    Nanosphere is headquartered in Northbrook, IL.

  • What is the size of Nanosphere?

    Nanosphere has 142 total employees.

  • What industry is Nanosphere in?

    Nanosphere’s primary industry is Diagnostic Equipment.

  • Is Nanosphere a private or public company?

    Nanosphere is a Private company.

  • What is the current valuation of Nanosphere?

    The current valuation of Nanosphere is .

  • What is Nanosphere’s current revenue?

    The current revenue for Nanosphere is .

  • How much funding has Nanosphere raised over time?

    Nanosphere has raised $242M.

  • Who are Nanosphere’s investors?

    Allen & Company., Bain Capital Ventures, Lurie Investment Fund, N*GEN Partners, and Oxford Finance are 5 of 9 investors who have invested in Nanosphere.

  • Who are Nanosphere’s competitors?

    Biocartis, Hain Lifescience, BioGenex Laboratories, Chembio Diagnostic Systems, and Response Genetics are some of the 31 competitors of Nanosphere.

  • When was Nanosphere acquired?

    Nanosphere was acquired on 30-Jun-2016.

  • Who acquired Nanosphere?

    Nanosphere was acquired by Luminex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process